• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机断层扫描评估的宫颈大小和盆腔淋巴结状态对接受根治性放射治疗的子宫颈癌患者的预后价值。

Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.

作者信息

Toita T, Nakano M, Higashi M, Sakumoto K, Kanazawa K

机构信息

Department of Radiology, University of the Ryukyus School of Medicine, Okinawa, Japan.

出版信息

Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):843-9. doi: 10.1016/0360-3016(95)00204-5.

DOI:10.1016/0360-3016(95)00204-5
PMID:7591892
Abstract

PURPOSE

To determine the prognostic impact of cervical size and pelvic lymph node status assessed by computed tomography (CT) in uterine cervical carcinoma treated with irradiation alone.

METHODS AND MATERIALS

Seventy patients with International Federation of Gynecology and Obstetrics (FIGO) Stage IIB and IIIB uterine cervical squamous cell carcinoma treated with a combination of external and high dose-rate intracavitary irradiation were entered into analyses. Univariate and multivariate analyses using the Cox regression model were performed to determine statistical significance of some tumor-related factors.

RESULTS

There were no significant differences in pelvic control rate (PC), distant metastases-free rate (DMF), cause-specific disease-free survival rate (CSDFS) among subgroups with cervix < 60 mm in diameter. However, PC (p = 0.023), DMF (p = 0.000025), and CSDFS (p = 0.0023) were significantly lower for patients with cervix > or = 60 mm than < 60 mm. The 5-year CSDFS was 77.5% for < 60 mm, and 28.6% for > or = 60 mm. Pelvic node status assessed by CT scans had significant prognostic impact on outcome. the 5-year CSDFS rate was 84.9% for patients with no enlarged nodes, and 58.9% for those with enlarged nodes greater than 1 cm in minimum diameter (p = 0.023). Whereas PC was not significantly affected, the DMF was strongly correlated with nodal status (p = 0.00027). Pelvic node status was taken as an independent predictor for DMF (p = 0.019) on multivariate analysis.

CONCLUSION

Although cervical size assessed by CT had limited prognostic value, pelvic node status assessed by CT is the significant prognostic factor for patients with uterine cervical carcinoma treated with radical irradiation.

摘要

目的

确定在单纯接受放疗的子宫颈癌中,通过计算机断层扫描(CT)评估的宫颈大小和盆腔淋巴结状态对预后的影响。

方法和材料

纳入70例接受外照射和高剂量率腔内照射联合治疗的国际妇产科联盟(FIGO)IIB期和IIIB期子宫颈鳞状细胞癌患者进行分析。使用Cox回归模型进行单因素和多因素分析,以确定一些肿瘤相关因素的统计学意义。

结果

直径<60mm的亚组间盆腔控制率(PC)、无远处转移率(DMF)、病因特异性无病生存率(CSDFS)无显著差异。然而,宫颈直径≥60mm的患者的PC(p = 0.023)、DMF(p = 0.000025)和CSDFS(p = 0.0023)显著低于<60mm的患者。<60mm的患者5年CSDFS为77.5%,≥60mm的患者为28.6%。CT扫描评估的盆腔淋巴结状态对预后有显著影响。无淋巴结肿大的患者5年CSDFS率为84.9%,最小直径大于1cm的淋巴结肿大患者为58.9%(p = 0.023)。虽然PC未受到显著影响,但DMF与淋巴结状态密切相关(p = 0.00027)。多因素分析中,盆腔淋巴结状态被视为DMF的独立预测因素(p = 0.019)。

结论

虽然CT评估的宫颈大小预后价值有限,但CT评估的盆腔淋巴结状态是接受根治性放疗的子宫颈癌患者的重要预后因素。

相似文献

1
Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.计算机断层扫描评估的宫颈大小和盆腔淋巴结状态对接受根治性放射治疗的子宫颈癌患者的预后价值。
Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):843-9. doi: 10.1016/0360-3016(95)00204-5.
2
Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation.
Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):777-82. doi: 10.1016/s0360-3016(98)00481-7.
3
[Prognostic value of anemia for patients with cervical cancer treated with irradiation].[贫血对接受放疗的宫颈癌患者的预后价值]
Medicina (Kaunas). 2005;41(11):916-24.
4
The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.单纯放疗的子宫颈癌患者预后因素的价值。
BMC Cancer. 2007 Dec 22;7:234. doi: 10.1186/1471-2407-7-234.
5
Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.肿瘤大小对术前放疗及手术治疗的子宫颈癌IB期和IIA期预后无影响。
Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):645-51. doi: 10.1016/s0360-3016(99)00217-5.
6
Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.早期子宫颈癌术后放疗:治疗结果及预后因素
Gynecol Oncol. 1999 Jan;72(1):10-5. doi: 10.1006/gyno.1998.5217.
7
Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.宫颈癌根治性放疗前肿瘤栓塞的预后影响分析
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1399-404. doi: 10.1016/j.ijrobp.2004.12.037.
8
Analysis of prognostic factors in stage IIB-IVA cervical carcinoma treated with radiation therapy: value of computed tomography.IIB-IVA期宫颈癌放疗预后因素分析:计算机断层扫描的价值
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1071-7. doi: 10.1016/s0360-3016(96)00599-8.
9
Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.接受体外照射和铱-192高剂量率近距离放射治疗的子宫颈癌患者的预后因素
Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):531-40. doi: 10.1016/s0360-3016(98)00255-7.
10
Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.盆腔淋巴结 F-18 氟代脱氧葡萄糖摄取作为局部晚期宫颈癌初诊患者的预后生物标志物。
Cancer. 2010 Mar 15;116(6):1469-75. doi: 10.1002/cncr.24972.

引用本文的文献

1
A Brief Overview of Oncogenes and Signal Transduction Pathways in Gynecological Cancer.妇科癌症中癌基因与信号转导通路概述
Cancer Diagn Progn. 2022 Mar 3;2(2):134-143. doi: 10.21873/cdp.10087. eCollection 2022 Mar-Apr.
2
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.2018年国际妇产科联盟(FIGO)IB1、IB2和IIA1期宫颈癌预后列线图的开发与验证:一项大型多中心研究
Ann Transl Med. 2022 Jan;10(2):121. doi: 10.21037/atm-21-6367.
3
Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
基于2018年国际妇产科联盟(FIGO)分期的诺模图预测接受根治性放疗的FIGO II至III期宫颈鳞状细胞癌患者的总生存期:一项回顾性分析
Cancer Manag Res. 2021 Dec 29;13:9391-9400. doi: 10.2147/CMAR.S336892. eCollection 2021.
4
Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?外照射放疗对盆腔淋巴结的提升是否能改善局部晚期宫颈癌患者的预后?
BMC Cancer. 2019 Apr 25;19(1):385. doi: 10.1186/s12885-019-5594-4.
5
The impact of irradiation dose on the computed tomography radiographic response of metastatic nodes and clinical outcomes in cervix cancer in a low-resource setting.在资源匮乏地区,照射剂量对子宫颈癌转移淋巴结的计算机断层扫描影像学反应及临床结局的影响。
South Asian J Cancer. 2017 Apr-Jun;6(2):54-58. doi: 10.4103/2278-330X.208856.
6
Bromocriptine therapy for the treatment of invasive prolactinoma: the single institute experience.溴隐亭治疗侵袭性泌乳素瘤:单机构经验
Brain Tumor Res Treat. 2013 Oct;1(2):71-7. doi: 10.14791/btrt.2013.1.2.71. Epub 2013 Oct 31.
7
External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.子宫颈癌临床阳性盆腔淋巴结患者的体外束增敏照射。
J Radiat Res. 2013 Jul 1;54(4):690-6. doi: 10.1093/jrr/rrs138. Epub 2013 Jan 29.
8
Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy.根治性放疗治疗阴道浸润性癌:高剂量率腔内近距离放疗的影响。
Int J Clin Oncol. 2013 Apr;18(2):314-20. doi: 10.1007/s10147-012-0379-7. Epub 2012 Feb 7.
9
The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.单纯放疗的子宫颈癌患者预后因素的价值。
BMC Cancer. 2007 Dec 22;7:234. doi: 10.1186/1471-2407-7-234.